Reuters logo
BRIEF-EMA recommends approval of Daiichi Sankyo's anticoagulant
February 24, 2017 / 12:24 PM / 7 months ago

BRIEF-EMA recommends approval of Daiichi Sankyo's anticoagulant

Feb 24 (Reuters) - EU Medicines Agency:

* EU medicines Agency recommendations for February 2017

* EU Medicines Agency recommends approval Of Daiichi Sankyo’s anticoagulant Edoxaban

* EU Medicines Agency says adopted positive opinion recommending changes to the terms of the marketing authorisation for the medicinal product Darzalex

* EU Medicines Agency recommends approval of Hospira UK Limited's Pemetrexed for treatment of non-small cell lung cancer Source (bit.ly/2lCHPks) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below